These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1337 related articles for article (PubMed ID: 10353737)
1. Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast. Brown LF; Guidi AJ; Schnitt SJ; Van De Water L; Iruela-Arispe ML; Yeo TK; Tognazzi K; Dvorak HF Clin Cancer Res; 1999 May; 5(5):1041-56. PubMed ID: 10353737 [TBL] [Abstract][Full Text] [Related]
2. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in endometrial carcinoma. Guidi AJ; Abu-Jawdeh G; Tognazzi K; Dvorak HF; Brown LF Cancer; 1996 Aug; 78(3):454-60. PubMed ID: 8697391 [TBL] [Abstract][Full Text] [Related]
3. Invasive lobular and invasive ductal carcinoma of the breast show distinct patterns of vascular endothelial growth factor expression and angiogenesis. Lee AH; Dublin EA; Bobrow LG; Poulsom R J Pathol; 1998 Aug; 185(4):394-401. PubMed ID: 9828838 [TBL] [Abstract][Full Text] [Related]
4. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract. Brown LF; Berse B; Jackman RW; Tognazzi K; Manseau EJ; Senger DR; Dvorak HF Cancer Res; 1993 Oct; 53(19):4727-35. PubMed ID: 8402650 [TBL] [Abstract][Full Text] [Related]
5. Strong expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in ovarian borderline and malignant neoplasms. Abu-Jawdeh GM; Faix JD; Niloff J; Tognazzi K; Manseau E; Dvorak HF; Brown LF Lab Invest; 1996 Jun; 74(6):1105-15. PubMed ID: 8667614 [TBL] [Abstract][Full Text] [Related]
6. VEGF, flt-1, and KDR/flk-1 as prognostic indicators in endometrial carcinoma. Fine BA; Valente PT; Feinstein GI; Dey T Gynecol Oncol; 2000 Jan; 76(1):33-9. PubMed ID: 10620438 [TBL] [Abstract][Full Text] [Related]
7. [Expression of vascular endothelial growth factor and its receptor (Flt-1) in breast carcinoma]. Wu H; Li Y; Zhu G; Zhang L; Zhang X; He X Zhonghua Yi Xue Za Zhi; 2002 May; 82(10):708-11. PubMed ID: 12133473 [TBL] [Abstract][Full Text] [Related]
8. Uterine smooth muscle cells express functional receptors (flt-1 and KDR) for vascular permeability factor/vascular endothelial growth factor. Brown LF; Detmar M; Tognazzi K; Abu-Jawdeh G; Iruela-Arispe ML Lab Invest; 1997 Feb; 76(2):245-55. PubMed ID: 9042161 [TBL] [Abstract][Full Text] [Related]
9. The short form of the alternatively spliced flt-4 but not its ligand vascular endothelial growth factor C is related to lymph node metastasis in human breast cancers. Gunningham SP; Currie MJ; Han C; Robinson BA; Scott PA; Harris AL; Fox SB Clin Cancer Res; 2000 Nov; 6(11):4278-86. PubMed ID: 11106244 [TBL] [Abstract][Full Text] [Related]
10. Radial scars of the breast and breast carcinomas have similar alterations in expression of factors involved in vascular stroma formation. Jacobs TW; Schnitt SJ; Tan X; Brown LF Hum Pathol; 2002 Jan; 33(1):29-38. PubMed ID: 11823971 [TBL] [Abstract][Full Text] [Related]
11. The effect of versican G3 domain on local breast cancer invasiveness and bony metastasis. Yee AJ; Akens M; Yang BL; Finkelstein J; Zheng PS; Deng Z; Yang B Breast Cancer Res; 2007; 9(4):R47. PubMed ID: 17662123 [TBL] [Abstract][Full Text] [Related]
12. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression. Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739 [TBL] [Abstract][Full Text] [Related]
13. [Correlation of angiogenesis with expression of vascular endothelial growth factor and its receptors in lung carcinoma]. Zhang G; Zhao M; Xu M; Yang Y; Wang M; Yang C Zhonghua Jie He He Hu Xi Za Zhi; 2002 Feb; 25(2):89-93. PubMed ID: 11953105 [TBL] [Abstract][Full Text] [Related]
14. Correlation between vascular endothelial growth factor, angiogenesis, and tumor-associated macrophages in invasive ductal breast carcinoma. Valković T; Dobrila F; Melato M; Sasso F; Rizzardi C; Jonjić N Virchows Arch; 2002 Jun; 440(6):583-8. PubMed ID: 12070596 [TBL] [Abstract][Full Text] [Related]
15. Monitoring metastatic behavior of human tumor cells in mice with species-specific polymerase chain reaction: elevated expression of angiogenesis and bone resorption stimulators by breast cancer in bone metastases. van der Pluijm G; Sijmons B; Vloedgraven H; Deckers M; Papapoulos S; Löwik C J Bone Miner Res; 2001 Jun; 16(6):1077-91. PubMed ID: 11393785 [TBL] [Abstract][Full Text] [Related]
16. Up-regulation of vascular endothelial growth factor and its receptors in von Hippel-Lindau disease-associated and sporadic hemangioblastomas. Wizigmann-Voos S; Breier G; Risau W; Plate KH Cancer Res; 1995 Mar; 55(6):1358-64. PubMed ID: 7533661 [TBL] [Abstract][Full Text] [Related]
17. Treatment for malignant pleural effusion of human lung adenocarcinoma by inhibition of vascular endothelial growth factor receptor tyrosine kinase phosphorylation. Yano S; Herbst RS; Shinohara H; Knighton B; Bucana CD; Killion JJ; Wood J; Fidler IJ Clin Cancer Res; 2000 Mar; 6(3):957-65. PubMed ID: 10741721 [TBL] [Abstract][Full Text] [Related]
18. Loss of the tight junction protein claudin-7 correlates with histological grade in both ductal carcinoma in situ and invasive ductal carcinoma of the breast. Kominsky SL; Argani P; Korz D; Evron E; Raman V; Garrett E; Rein A; Sauter G; Kallioniemi OP; Sukumar S Oncogene; 2003 Apr; 22(13):2021-33. PubMed ID: 12673207 [TBL] [Abstract][Full Text] [Related]
19. VEGF-B expression in human primary breast cancers is associated with lymph node metastasis but not angiogenesis. Gunningham SP; Currie MJ; Han C; Robinson BA; Scott PA; Harris AL; Fox SB J Pathol; 2001 Mar; 193(3):325-32. PubMed ID: 11241411 [TBL] [Abstract][Full Text] [Related]
20. Up-regulation of vascular endothelial growth factor/vascular permeability factor in mouse skin carcinogenesis correlates with malignant progression state and activated H-ras expression levels. Larcher F; Robles AI; Duran H; Murillas R; Quintanilla M; Cano A; Conti CJ; Jorcano JL Cancer Res; 1996 Dec; 56(23):5391-6. PubMed ID: 8968091 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]